Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
The Signia Circular Stapler is the only circular stapler on the market with integrated leak testing and features designed to minimize risk
The European Commission’s green light marks Breyanzi’s fourth indication in Europe and extends access to patients across all EU and EEA countries
Elevidys came under scrutiny in June when the FDA disclosed two fatal cases in non-ambulatory boys who developed dangerously high liver enzyme levels
Adzynma, approved for both adults and children with cTTP, is a recombinant enzyme therapy designed to replace the deficient ADAMTS13 enzyme
The approvals target adult MIBC patients who are ineligible for cisplatin-based chemotherapy
The X CUBE 50 integrates ALPINION’s advanced X+ Architecture
The collaboration to develop breakthrough myeloid cell engagers (MCEs) signals a bold push into a promising new frontier in cancer therapy
Subscribe To Our Newsletter & Stay Updated